|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
52,907,000 |
Market
Cap: |
N/A |
Last
Volume: |
678,324 |
Avg
Vol: |
305,337 |
52
Week Range: |
$11.15 - $11.15 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cavazza Paolo |
10% Owner |
|
2005-05-11 |
4 |
B |
$2.53 |
$4,303 |
I/I |
1,700 |
159,898 |
1.42 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-05-10 |
4 |
B |
$0.00 |
$35,000 |
I/I |
14,000 |
501,069 |
1.5 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-05-10 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
572,815 |
2.37 |
- |
|
Cavazza Claudio |
10% Owner |
|
2005-05-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
0 |
394,615 |
|
- |
|
Cavazza Claudio |
10% Owner |
|
2005-05-06 |
4 |
OE |
$5.00 |
$169,000 |
I/I |
33,800 |
3,571,658 |
|
- |
|
Cavazza Paolo |
10% Owner |
|
2005-05-06 |
4 |
OE |
$0.00 |
$169,000 |
I/I |
33,800 |
501,069 |
|
- |
|
Cavazza Paolo |
10% Owner |
|
2005-05-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
0 |
572,815 |
|
- |
|
Defiante Farmaceutica Lda |
10% Owner |
|
2005-05-06 |
4 |
OE |
$5.00 |
$169,000 |
I/I |
33,800 |
3,571,658 |
|
- |
|
Cavazza Claudio |
10% Owner |
|
2005-04-18 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
394,615 |
2.37 |
- |
|
Cavazza Claudio |
10% Owner |
|
2005-04-18 |
4 |
B |
$2.70 |
$1,299 |
I/I |
481 |
3,537,858 |
1.42 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-04-18 |
4 |
B |
$0.00 |
$1,299 |
I/I |
481 |
501,069 |
1.42 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-04-18 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
572,815 |
2.37 |
- |
|
Defiante Farmaceutica Lda |
10% Owner |
|
2005-04-18 |
4 |
B |
$2.70 |
$1,299 |
I/I |
481 |
3,537,858 |
1.42 |
- |
|
Cavazza Claudio |
10% Owner |
|
2005-04-15 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
394,615 |
2.37 |
- |
|
Cavazza Claudio |
10% Owner |
|
2005-04-15 |
4 |
B |
$2.70 |
$11,788 |
I/I |
4,366 |
3,537,377 |
1.5 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-04-15 |
4 |
B |
$2.70 |
$46,936 |
I/I |
17,390 |
144,198 |
1.5 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-04-15 |
4 |
B |
$0.00 |
$11,788 |
I/I |
4,366 |
501,069 |
1.5 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-04-15 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
572,815 |
2.37 |
- |
|
Defiante Farmaceutica Lda |
10% Owner |
|
2005-04-15 |
4 |
B |
$2.70 |
$11,788 |
I/I |
4,366 |
3,537,377 |
1.5 |
- |
|
Cavazza Claudio |
10% Owner |
|
2005-04-14 |
4 |
B |
$2.80 |
$70,389 |
I/I |
25,139 |
3,533,011 |
1.5 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-04-14 |
4 |
B |
$2.80 |
$70,389 |
I/I |
25,139 |
3,533,011 |
1.5 |
- |
|
Defiante Farmaceutica Lda |
10% Owner |
|
2005-04-14 |
4 |
B |
$2.80 |
$70,389 |
I/I |
25,139 |
3,533,011 |
1.5 |
- |
|
Cavazza Claudio |
10% Owner |
|
2005-03-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
0 |
394,615 |
|
- |
|
Cavazza Claudio |
10% Owner |
|
2005-03-30 |
4 |
OE |
$5.00 |
$2,500 |
I/I |
500 |
3,507,872 |
|
- |
|
Cavazza Paolo |
10% Owner |
|
2005-03-30 |
4 |
OE |
$5.00 |
$2,500 |
I/I |
500 |
3,507,872 |
|
- |
|
565 Records found
|
|
Page 21 of 23 |
|
|